Quik M, Choremis J, Komourian J, Lukas R J, Puchacz E
Department of Pharmacology, McGill University, Montreal, Quebec, Canada.
J Neurochem. 1996 Jul;67(1):145-54. doi: 10.1046/j.1471-4159.1996.67010145.x.
The present results demonstrate stable expression of alpha-bungarotoxin (alpha-BGT) binding sites by cells of the GH4C1 rat pituitary clonal line. Wild-type GH4C1 cells do not express alpha-BGT binding sites, nor do they contain detectable mRNA for nicotinic receptor alpha2, alpha3, alpha4, alpha5, alpha7, beta2, or beta3 subunits. However, GH4C1 cells stably transfected with rat nicotinic receptor alpha7 cDNA (alpha7/GH4C1 cells) express the transgene abundantly as mRNA, and northern analysis showed that the message is of teh predicted size. The alpha7/GH4C1 cells also express saturable, high-affinity binding sites for 125I-labeled alpha-BGT, with a KD of 0.4 nM and Bmax of 3.2 fmol/10(6) intact cells. 125I-alpha-BGT binding affinities and pharmacological profiles are not significantly different for sites in membranes prepared either from rat brain or alpha7/GH4C1 cells. Furthermore, KD and Ki values for 125I-alpha-BGT binding sites on intact alpha7/GH4C1 cells are essentially similar to those for hippocampal neurons in culture. Sucrose density gradient analysis showed that the size of the alpha-BGT binding sites expressed in alpha7/GH4C1 cells was similar to that of the native brain alpha-BGT receptor. Chronic exposure of alpha7/GH4C1 cells in culture to nicotine or an elevated extracellular potassium concentration induces changes in the number of alpha-BGT binding sites comparable to those observed in cultured neurons. Collectively, the present results show that the properties of alpha-BGT binding sites in transfected alpha7/GH4C1 cells resemble those for brain nicotinic alpha-BGT receptors. If the heterologously expressed alpha-BGT binding sites in the present study are composed solely of alpha7 subunits, the results could suggest that the rat brain alpha-BGT receptor has a similar homooligomeric structure. Alternatively, if alpha-BGT binding sites exist as heterooligomers of alpha7 plus some other previously identified or novel subunit(s), the data would indicate that the alpha7 subunits play a major role in determining properties of the alpha-BGT receptor.
目前的结果表明,GH4C1大鼠垂体克隆系的细胞能稳定表达α-银环蛇毒素(α-BGT)结合位点。野生型GH4C1细胞不表达α-BGT结合位点,也不含有可检测到的烟碱型受体α2、α3、α4、α5、α7、β2或β3亚基的mRNA。然而,稳定转染大鼠烟碱型受体α7 cDNA的GH4C1细胞(α7/GH4C1细胞)大量表达转基因mRNA,Northern分析表明该信息为预测大小。α7/GH4C1细胞还表达对125I标记的α-BGT具有饱和性、高亲和力的结合位点,KD为0.4 nM,Bmax为3.2 fmol/10(6)个完整细胞。对于从大鼠脑或α7/GH4C1细胞制备的膜中的位点,125I-α-BGT的结合亲和力和药理学特性没有显著差异。此外,完整的α7/GH4C1细胞上125I-α-BGT结合位点的KD和Ki值与培养的海马神经元基本相似。蔗糖密度梯度分析表明,α7/GH4C1细胞中表达的α-BGT结合位点的大小与天然脑α-BGT受体的大小相似。在培养中,将α7/GH4C1细胞长期暴露于尼古丁或细胞外钾浓度升高的环境中,会诱导α-BGT结合位点数量的变化,这与在培养神经元中观察到的变化相当。总体而言,目前的结果表明,转染的α7/GH4C1细胞中α-BGT结合位点的特性类似于脑烟碱型α-BGT受体的特性。如果本研究中异源表达的α-BGT结合位点仅由α7亚基组成,结果可能表明大鼠脑α-BGT受体具有类似的同聚体结构。或者,如果α-BGT结合位点以α7与一些其他先前鉴定的或新的亚基的异聚体形式存在,数据将表明α7亚基在决定α-BGT受体的特性中起主要作用。